FEATURED COMPANIES
- Akorn
- Apotex Inc
- Catalent Inc
- GlaxoSmithKline
- Novartis International AG
- Proctor and Gamble Co
This report denotes that the global nasal spray market is forecasted to register growth at a CAGR of 8.47% from 2021 to 2028.
Factors such as emerging intranasal vaccines for COVID-19, rising acceptance of self-administration of medication, and increasing use of nasal sprays are driving the progression of the studied market globally. Additionally, the application of nasal sprays in treating depression is creating numerous opportunities for the nasal spray market.
Conversely, complications due to the excess use of nasal sprays negatively impact the global market's overall development.
The global nasal spray market covers North America, Asia-Pacific, Latin America, Europe, Middle East and Africa regions.
Globally, the Asia-Pacific is anticipated to witness the fastest growth in the nasal spray market over the estimated phase. In recent years, allergic diseases have surged significantly in the region due to extensive urbanization and rising environmental pollution. Besides, the more prevalent causes of respiratory morbidity are smoking, infection, and air pollution. Some of the major respiratory diseases include TB and occupational lung diseases. Such factors have influenced the adoption of nasal spray among the population, thereby driving the nasal spray market’s growth in the APAC region.
The well-known companies in the nasal spray market consist of Sun Pharmaceuticals Industries Ltd, Johnson and Johnson, Novartis International AG, Sanotize Research and Development, Bharat Biotech, Viatris, Akorn, GlaxoSmithKline, Proctor and Gamble Co, Pfizer Inc, Catalent Inc, Cipla Limited, Allergan, Apotex Inc, and Teva Pharmaceutical Industries Ltd.
Johnson and Johnson is involved in the R&D, manufacture, and sale of various products in the healthcare sector. Its business segment includes consumer, pharmaceutical, and medical devices. The pharmaceutical segment provides products relating to immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and metabolism. Moreover, the company has operations across various regions, including Europe, the Middle East and Africa, the Asia-Pacific, and Latin America. It is headquartered in New Jersey, the United States.
Factors such as emerging intranasal vaccines for COVID-19, rising acceptance of self-administration of medication, and increasing use of nasal sprays are driving the progression of the studied market globally. Additionally, the application of nasal sprays in treating depression is creating numerous opportunities for the nasal spray market.
Conversely, complications due to the excess use of nasal sprays negatively impact the global market's overall development.
REGIONAL OUTLOOK
The global nasal spray market covers North America, Asia-Pacific, Latin America, Europe, Middle East and Africa regions.
Globally, the Asia-Pacific is anticipated to witness the fastest growth in the nasal spray market over the estimated phase. In recent years, allergic diseases have surged significantly in the region due to extensive urbanization and rising environmental pollution. Besides, the more prevalent causes of respiratory morbidity are smoking, infection, and air pollution. Some of the major respiratory diseases include TB and occupational lung diseases. Such factors have influenced the adoption of nasal spray among the population, thereby driving the nasal spray market’s growth in the APAC region.
COMPETITIVE OUTLOOK
The well-known companies in the nasal spray market consist of Sun Pharmaceuticals Industries Ltd, Johnson and Johnson, Novartis International AG, Sanotize Research and Development, Bharat Biotech, Viatris, Akorn, GlaxoSmithKline, Proctor and Gamble Co, Pfizer Inc, Catalent Inc, Cipla Limited, Allergan, Apotex Inc, and Teva Pharmaceutical Industries Ltd.
Johnson and Johnson is involved in the R&D, manufacture, and sale of various products in the healthcare sector. Its business segment includes consumer, pharmaceutical, and medical devices. The pharmaceutical segment provides products relating to immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and metabolism. Moreover, the company has operations across various regions, including Europe, the Middle East and Africa, the Asia-Pacific, and Latin America. It is headquartered in New Jersey, the United States.
Frequently Asked Questions about the Global Nasal Spray Market
What is the estimated value of the Global Nasal Spray Market?
What is the growth rate of the Global Nasal Spray Market?
What is the forecasted size of the Global Nasal Spray Market?
Who are the key companies in the Global Nasal Spray Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Akorn
- Apotex Inc
- Catalent Inc
- GlaxoSmithKline
- Novartis International AG
- Proctor and Gamble Co
1. Global Nasal Spray Market - Summary
2. Industry Outlook
3. Global Nasal Spray Market Outlook - by Type
4. Global Nasal Spray Market Outlook - by Prescription
5. Global Nasal Spray Market Outlook - by Therapeutic
6. Global Nasal Spray Market Outlook - by Application
7. Global Nasal Spray Market Outlook - by End-User
8. Global Nasal Spray Market - Regional Outlook
9. Competitive Landscape
10. Research Methodology & Scope
Table List
Figure List
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Akorn
- Allergan
- Apotex Inc
- Bharat Biotech
- Catalent Inc
- Cipla Limited
- GlaxoSmithKline
- Johnson and Johnson
- Novartis International AG
- Pfizer Inc
- Proctor and Gamble Co
- Sanotize Research and Development
- Sun Pharmaceuticals Industries Ltd
- Teva Pharmaceutical Industries Ltd
- Viatris
Note: Product cover images may vary from those shown
LOADING...